Zhikun Liu

2.3k total citations
115 papers, 1.5k citations indexed

About

Zhikun Liu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zhikun Liu has authored 115 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 35 papers in Oncology and 33 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zhikun Liu's work include Esophageal Cancer Research and Treatment (15 papers), Lung Cancer Diagnosis and Treatment (15 papers) and Hepatocellular Carcinoma Treatment and Prognosis (13 papers). Zhikun Liu is often cited by papers focused on Esophageal Cancer Research and Treatment (15 papers), Lung Cancer Diagnosis and Treatment (15 papers) and Hepatocellular Carcinoma Treatment and Prognosis (13 papers). Zhikun Liu collaborates with scholars based in China, Madagascar and United Kingdom. Zhikun Liu's co-authors include Xiao Xu, Shusen Zheng, Haiyang Xie, Shaohua Gou, Heng‐Shan Wang, Xuyong Wei, Lin Zhou, Qi Ling, Yichao Wu and Shusen Zheng and has published in prestigious journals such as Journal of Hazardous Materials, Scientific Reports and ACS Applied Materials & Interfaces.

In The Last Decade

Zhikun Liu

107 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhikun Liu China 23 653 411 394 259 241 115 1.5k
Sven A. Lang Germany 24 928 1.4× 449 1.1× 298 0.8× 174 0.7× 121 0.5× 44 1.5k
Jian Zhu China 27 1.0k 1.5× 489 1.2× 626 1.6× 132 0.5× 179 0.7× 86 2.0k
Yukio Morishita Japan 23 768 1.2× 628 1.5× 243 0.6× 343 1.3× 385 1.6× 97 2.0k
Sachiko Ogasawara Japan 22 740 1.1× 519 1.3× 406 1.0× 163 0.6× 179 0.7× 78 1.6k
Peihua Luo China 28 934 1.4× 465 1.1× 190 0.5× 300 1.2× 85 0.4× 94 1.8k
Kazuya Koizumi Japan 16 365 0.6× 673 1.6× 163 0.4× 392 1.5× 527 2.2× 101 1.5k
Neil H. James United Kingdom 22 1.0k 1.5× 545 1.3× 303 0.8× 172 0.7× 82 0.3× 28 1.5k

Countries citing papers authored by Zhikun Liu

Since Specialization
Citations

This map shows the geographic impact of Zhikun Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhikun Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhikun Liu more than expected).

Fields of papers citing papers by Zhikun Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhikun Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhikun Liu. The network helps show where Zhikun Liu may publish in the future.

Co-authorship network of co-authors of Zhikun Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhikun Liu. A scholar is included among the top collaborators of Zhikun Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhikun Liu. Zhikun Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Meng, Guimei Li, Ri-Zhen Huang, et al.. (2025). Discovery of a Novel EF24 Analogue-Conjugated Pt(IV) Complex as Multi-Target Pt(IV) Prodrugs Aims to Enhance Anticancer Activity and Overcome Cisplatin Resistance. Journal of Medicinal Chemistry. 68(5). 5597–5615.
2.
3.
Huang, Xiaochao, Jian Tang, Guimei Li, et al.. (2025). Discovery of novel combretastatin A4 derivatives as a microtubule targeting agent capable of inducing HepG-2 cell apoptosis via the mitochondria and ER stress mediated pathway. Bioorganic Chemistry. 163. 108676–108676. 1 indexed citations
4.
Tang, Zhi, et al.. (2024). Zebrafish as a Model Organism for Congenital Hydrocephalus: Characteristics and Insights. Zebrafish. 21(6). 361–384. 2 indexed citations
5.
Li, Jie, Zhikun Liu, Jianguo Wang, et al.. (2024). Tumor Promoting Effect of Long Non-Coding RNA RP11-556E13.1 and its Clinical Significance in Hepatocellular Carcinoma. Clinical Laboratory. 70(02/2024). 1 indexed citations
6.
Liu, Zhikun, Guiyang Jiang, Meng Wang, et al.. (2023). Novel Platinum(IV) complexes intervene oxaliplatin resistance in colon cancer via inducing ferroptosis and apoptosis. European Journal of Medicinal Chemistry. 263. 115968–115968. 9 indexed citations
7.
Yang, Fan, Xiaoyong Shen, Yichao Wu, et al.. (2023). Application of multi-modality MRI-based radiomics in the pre-treatment prediction of RPS6K expression in hepatocellular carcinoma. Molecular Biomedicine. 4(1). 22–22. 3 indexed citations
8.
Wang, Duan, et al.. (2023). Identification of the WRKY gene family in apricot and its response to drought stress. Horticulture Environment and Biotechnology. 64(2). 269–282. 7 indexed citations
9.
Wu, Yichao, Zhikun Liu, & Xiao Xu. (2020). Molecular subtyping of hepatocellular carcinoma: A step toward precision medicine. Cancer Communications. 40(12). 681–693. 44 indexed citations
10.
Shen, Wenbin, Yufang Wang, Hongmei Gao, et al.. (2019). Dosimetric Predictors of Radiation Gastritis Due to Postoperative Intensity Modulated Irradiation Therapy in Patients with Esophageal Squamous Cell Carcinoma After Radical Esophagectomy. Cancer Biotherapy and Radiopharmaceuticals. 34(7). 419–426. 2 indexed citations
11.
Shen, Wenbin, Hongmei Gao, Shuchai Zhu, et al.. (2018). Abdominal lymph node recurrence after radical surgery in patients with middle thoracic esophageal squamous cell carcinoma: risk factors and guidance for postoperative radiotherapy. Zhonghua fangshe zhongliuxue zazhi. 27(2). 135–139. 1 indexed citations
12.
Shen, Wenbin, Hongmei Gao, Li Teng, et al.. (2017). Analysis of postoperative failure in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma and consideration of postoperative radiotherapy. Zhonghua fangshe zhongliuxue zazhi. 26(4). 394–399. 1 indexed citations
13.
Li, Hongyun, et al.. (2016). An analysis of the influencing factors for long-term survival in patients with esophageal carcinoma undergoing radical chemoradiotherapy. Zhonghua fangshe zhongliuxue zazhi. 25(11). 1177–1181. 2 indexed citations
14.
Ma, Ming, et al.. (2016). Radiosensitization of esophageal carcinoma cells by knockdown of RNF2 expression. International Journal of Oncology. 48(5). 1985–1996. 17 indexed citations
15.
Dong, Hui, et al.. (2015). A comparative study of different irradiation ranges in radical radiotherapy for early-stage esophageal cancer. Zhonghua fangshe zhongliuxue zazhi. 24(6). 615–618. 1 indexed citations
16.
Li, Juan, Shuchai Zhu, Jing Tong, et al.. (2015). Suppression of lactate dehydrogenase A compromises tumor progression by downregulation of the Warburg effect in glioblastoma. Neuroreport. 27(2). 110–115. 56 indexed citations
17.
Zhu, Shuchai, et al.. (2014). A preliminary study of three-dimensional conformal radiotherapy with different clinical target volumes for esophageal cancer. Zhonghua fangshe zhongliuxue zazhi. 23(2). 127–130. 2 indexed citations
18.
Dong, Hui, et al.. (2014). A comparative study of failure patterns of definitive treatment of esophageal cancer with elective nodal irradiation and involved-field irradiation. Zhonghua fangshe zhongliuxue zazhi. 23(6). 479–483. 1 indexed citations
19.
Liu, Zhikun. (2012). Comparison of Clinical Efficacy and Complications in Three Common Methods for the Treatment of Axillary Osmidrosis. 1 indexed citations
20.
Li, Juan, et al.. (2012). Analysis the long-term effect of 375 patients with esophageal carcinoma treated by three-dimensional conformal radiotherapy. Zhonghua fangshe zhongliuxue zazhi. 21(4). 334–338. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sven A. Lang Breakdown of academic impact, for papers by Jian Zhu Breakdown of academic impact, for papers by Yukio Morishita Breakdown of academic impact, for papers by Sachiko Ogasawara Breakdown of academic impact, for papers by Peihua Luo Breakdown of academic impact, for papers by Kazuya Koizumi Breakdown of academic impact, for papers by Neil H. James
Rankless by CCL
2026